News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
Enveric Biosciences Appoints Dr. Bob Dagher as Chief Medical Officer
Enveric Biosciences
Tryp Therapeutics to Present at the H.C. Wainwright Psychedelics Conference on December 6, 2021
Tryp Therapeutics
KetamineOne Subsidiary KGK Science Helps Client Receive New Dietary Ingredient Status from U.S. FDA
Wellbeing Digital Sciences
Universal Ibogaine Announces Expansion of Executive Team andGrant of Stock Options
Universal Ibogaine
Psyence Group Announces Private Placement
Psyence Group
Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia
Tryp Therapeutics
Ketamine One Partners with Cognetivity Neurosciences in Collaborative Clinical Study on Depression and PTSD
Wellbeing Digital Sciences
PsyBio Therapeutics Sponsors 16 Collaborative Research Abstract Presentations at Two Scientific Conferences
PsyBio Therapeutics
Psychiatrist and Addiction Researcher, Dr. Henry Kranzler Joins Entheon Advisory Board
Entheon Biomedical
PsyBio Therapeutics to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference
PsyBio Therapeutics
MindMed to Present at H.C. Wainwright 2nd Annual Psychedelics Conference
Mind Medicine (MindMed)
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.